I chose the influence of public administration on pharmaceutical production as the topic of my thesis, as I have been very interested in this area and its regulation for some time. I have found that these institutions have a decisive influence on the conditions under which pharmaceutical companies can or cannot operate. Various research methods were employed in the thesis. The dogmatic and normative approaches facilitated a detailed analysis of the legal and regulatory framework, while the comparative method helped identify differences between European and other regulatory systems. Statistical analysis of data from the Slovenian Medicines Agency (JAZMP) offered a realistic picture of regulatory implementation in practice. Additionally, a case study provided a practical link between theory and real-world challenges. While standards for drug quality and safety are high, they are also demanding, as companies must continually adapt to regulatory changes, which in turn can affect their efficiency and development. This thesis is useful for newcomers seeking a comprehensive overview of the regulatory landscape as well as for companies undergoing licensing procedures. It contributes to a better understanding of how cooperation between the public administration and industry supports the development of a safe and high-quality pharmaceutical environment.
|
